Comparison of the short-term efficacy of MIS-TLIF and Endo-LIF for the treatment of two-segment lumbar degenerative disease
- PMID: 39232720
- PMCID: PMC11373331
- DOI: 10.1186/s12891-024-07815-1
Comparison of the short-term efficacy of MIS-TLIF and Endo-LIF for the treatment of two-segment lumbar degenerative disease
Abstract
Background: This study retrospectively compared short-term clinical outcomes and complications of minimally invasive surgery transforaminal lumbar interbody fusion(MIS-TLIF)and endoscopic lumbar interbody fusion(Endo-LIF))for two-segmental lumbar degenerative disease, aiming to guide spine surgeons in selecting surgical approaches.
Methods: From January 2019 to December 2023, 30 patients were enrolled,15 in the MIS-TLIF group and 15 in the Endo-LIF group. All patients were followed up for more than 3 months after surgery and the following information was recorded: (1)surgery time, difference in hemoglobin between preoperative and postoperative, surgical costs, first time out of bed after operation, postoperative hospitalization time, postoperative complication; (2) ODI score (The Oswestry Disability Index), leg and back VAS score (Visual Analogue Scale), and lumbar vertebra JOA score (Japanese Orthopaedic Association Scores); (3) MacNab score at final follow-up to assess clinical outcome, CT to evaluate lumbar fusion.
Results: There were significant differences between the two groups regarding operation time and cost, with the MIS-TLIF group performing significantly better. Intraoperative bleeding was considerably less in the Endo-LIF group compared to the MIS-TLIF group. However, there were no significant differences in the time of the first postoperative ambulation, postoperative hospitalization time, and postoperative complications. There was no significant difference in preoperative VAS, ODI, and JOA between the two surgical groups There were no significant differences in VAS(leg), ODI, and JOA scores between the two groups before and at 1 day,7 days, 1 month, 3 months and final follow-up. However, at 1 day postoperatively, the VAS( back)score in the Endo-LIF group was lower than that in the MIS-TLIF group, and the difference was statistically significant. At the final follow-up, all patients achieved grade III and above according to the Bridwell criteria, and there was no significant difference between the two surgical groups compared to each other. According to the MacNab score at the final follow-up, the excellent rate was 80.00% in the Endo-LIF group and 73.33% in the MIS-TLIF group, with no significant difference between the two groups.
Conclusion: There was no significant difference in short-term efficacy and safety between Endo-LIF and MIS-TLIF for two-segment degenerative lumbar diseases. MIS-TLIF has a shorter operative time and lower costs, while Endo-LIF causes less tissue damage, blood loss, and early postoperative pain, aiding long-term recovery. Both MIS-TLIF and Endo-LIF are promising for treating two-segment lumbar degenerative disease. The choice of a surgical procedure depends on the patient's financial situation, their ability to tolerate surgery, and the surgeon's expertise.
Keywords: Lumbar degenerative disease; Lumbar vertebrae; Minimally invasive; Minimally invasive surgery; Pedicle screw.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Comparison of minimally invasive transforaminal lumbar interbody fusion and endoscopic lumbar interbody fusion for lumbar degenerative diseases: a retrospective observational study.J Orthop Surg Res. 2023 May 27;18(1):389. doi: 10.1186/s13018-023-03875-6. J Orthop Surg Res. 2023. PMID: 37245051 Free PMC article.
-
Early Clinical Evaluation of Percutaneous Full-endoscopic Transforaminal Lumbar Interbody Fusion with Pedicle Screw Insertion for Treating Degenerative Lumbar Spinal Stenosis.Orthop Surg. 2021 Feb;13(1):328-337. doi: 10.1111/os.12900. Epub 2021 Jan 10. Orthop Surg. 2021. PMID: 33426744 Free PMC article.
-
Comparison of clinical efficacy and surgeon's neck flexion time between unilateral biportal endoscopic lumbar fusion versus minimally invasive transforaminal lumbar fusion in the treatment of single-level lumbar degenerative diseases: a single center retrospective study.BMC Musculoskelet Disord. 2025 Mar 25;26(1):296. doi: 10.1186/s12891-025-08406-4. BMC Musculoskelet Disord. 2025. PMID: 40133882 Free PMC article.
-
Endoscopic Lumbar Interbody Fusion and Minimally Invasive Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Degenerative Diseases: A Systematic Review and Meta-Analysis.World Neurosurg. 2021 Aug;152:e352-e368. doi: 10.1016/j.wneu.2021.05.109. Epub 2021 Jun 1. World Neurosurg. 2021. PMID: 34087465
-
Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion for single-segment lumbar degenerative disease: a meta-analysis.BMC Musculoskelet Disord. 2024 Nov 21;25(1):938. doi: 10.1186/s12891-024-08046-0. BMC Musculoskelet Disord. 2024. PMID: 39574056 Free PMC article.
Cited by
-
Endoscope-Assisted Spine Surgery: A Comprehensive Review of Clinical Applications and a Lateral Interbody Fusion Case Illustration.Cureus. 2025 Jun 23;17(6):e86600. doi: 10.7759/cureus.86600. eCollection 2025 Jun. Cureus. 2025. PMID: 40704233 Free PMC article.
-
[Short-term effectiveness of uni-portal non-coaxial spinal endoscopic surgery via crossing midline approach in treatment of free lumbar disc herniation].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025 Jan 15;39(1):83-87. doi: 10.7507/1002-1892.202409030. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2025. PMID: 39848721 Free PMC article. Chinese.
References
-
- Zhai WJ, Wang ZK, Liu HL, Qin SL, Han PF, Xu YF. Comparison between minimally invasive and open transforaminal lumbar interbody fusion for the treatment of multi–segmental lumbar degenerative disease: a systematic evaluation and meta–analysis. Exp Ther Med. 2024;27(4):162. 10.3892/etm.2024.12450. Published 2024 Feb 23. 10.3892/etm.2024.12450 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- 2024AFD130/Joint Fund for Innovation and Development of Natural Science Foundation of Hubei Province
- 2024AFD130/Joint Fund for Innovation and Development of Natural Science Foundation of Hubei Province
- 2024AFD130/Joint Fund for Innovation and Development of Natural Science Foundation of Hubei Province
LinkOut - more resources
Full Text Sources